NEXENTIS TECHNOLOGIES INC. Diluted Shares Outstanding (Weighted Average)
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Diluted Shares Outstanding (Weighted Average) of 816.14 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 816.14K shares, a 701.22% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 612.72K shares, a 500.85% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 2.76M shares.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 967.49K shares, a 83.38% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.29M shares, a 588.11% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 187.22K shares, a 84.41% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.20M shares, a 127.05% increase from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 528.78K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 816.14K shares 10-Q · filed 2026-08-13 | 1.02M shares 10-Q · filed 2026-08-13 | 1.40M shares derived: average of 3 quarters · filed 2026-08-13 | 1.29M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | 612.72K shares 10-Q · filed 2026-05-14 | 1.69M shares derived: average of 2 quarters · filed 2026-05-14 | 1.45M shares derived: average of 3 quarters · filed 2026-05-14 | 1.11M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | 2.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.86M shares derived: average of 2 quarters · filed 2026-03-31 | 1.28M shares derived: average of 3 quarters · filed 2026-08-13 | 1.29M shares 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 967.49K shares 10-Q · filed 2025-11-13 | 534.67K shares derived: average of 2 quarters · filed 2026-08-13 | 797.23K shares 10-Q · filed 2025-11-13 | -2.57M shares derived: average of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | 101.86K shares 10-Q · filed 2026-08-13 | 25.53M shares 10-Q · filed 2025-08-14 | 102.07K shares 10-Q · filed 2026-08-13 | 22.75M shares 10-Q · filed 2025-08-14 | -3.75M shares derived: average of 3 quarters · filed 2026-08-13 | -1.36M shares derived: average of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 101.97K shares 10-Q · filed 2026-05-14 | 22.29M shares 10-Q · filed 2025-05-15 | -5.68M shares derived: average of 2 quarters · filed 2026-05-14 | -1.85M shares derived: average of 3 quarters · filed 2026-05-14 | -532.27K shares derived: average of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -11.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -2.82M shares derived: average of 2 quarters · filed 2026-03-31 | -743.68K shares derived: average of 3 quarters · filed 2026-03-31 | 187.22K shares 10-K · filed 2026-03-31 | 5.85M shares 10-K · filed 2025-03-31 | ||
| 2024-09-30 | 5.82M shares 10-Q · filed 2024-11-14 | 4.61M shares derived: average of 2 quarters · filed 2024-11-14 | 4.07M shares 10-Q · filed 2024-11-14 | 3.48M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2024-06-30 | 3.41M shares 10-Q · filed 2024-08-14 | 3.18M shares 10-Q · filed 2024-08-14 | 2.70M shares derived: average of 3 quarters · filed 2025-05-15 | 2.36M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2024-03-31 | 2.96M shares 10-Q · filed 2025-05-15 | 2.35M shares derived: average of 2 quarters · filed 2025-05-15 | 2.01M shares derived: average of 3 quarters · filed 2025-05-15 | 1.77M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 1.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.54M shares derived: average of 2 quarters · filed 2025-03-31 | 1.37M shares derived: average of 3 quarters · filed 2025-03-31 | 1.20M shares 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 1.33M shares 10-Q · filed 2024-11-14 | 1.18M shares derived: average of 2 quarters · filed 2024-11-14 | 1.02M shares 10-Q · filed 2024-11-14 | 935.05K shares derived: average of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | 1.03M shares 10-Q · filed 2024-08-14 | 6.99M shares 10-Q · filed 2023-08-14 | 862.40K shares 10-Q · filed 2024-08-14 | 5.83M shares 10-Q · filed 2023-08-14 | 803.04K shares derived: average of 3 quarters · filed 2024-08-14 | 741.74K shares derived: average of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | 695.93K shares 10-Q · filed 2024-05-15 | 691.04K shares derived: average of 2 quarters · filed 2024-05-15 | 646.64K shares derived: average of 3 quarters · filed 2024-05-15 | 1.20M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 686.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 621.99K shares derived: average of 2 quarters · filed 2024-04-01 | 1.37M shares derived: average of 3 quarters · filed 2024-04-01 | 528.78K shares 10-K · filed 2024-04-01 | |||
| 2022-09-30 | 557.83K shares 10-Q · filed 2023-11-14 | 1.71M shares derived: average of 2 quarters · filed 2023-11-14 | 476.31K shares 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | 2.86M shares 10-Q · filed 2023-08-14 | 2.84M shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |